Frazier Healthcare Partners Closes $987 Million Life Sciences Fund

McGuireWoods LLP
Contact

Frazier Healthcare Partners has announced the closing of Frazier Life Sciences XI with more than $987 million in capital commitments.

The new fund, which exceeded its target of $800 million, is Frazier Life Sciences’ fourth venture fund focused on biopharmaceuticals.

The firm’s announcement of the new fund comes only a few months after it had announced the closing of an $830 million public-market fund.

Frazier Healthcare Partners, based in Seattle, is a provider of private equity capital to healthcare companies. The firm, founded in 1991, prefers to make more substantial investments from a dollars perspective and pursues a wide range of investment types, including company creation and venture capital to buyouts of profitable lower-middle market companies.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide